Lipella Pharmaceuticals Files For Chapter 11 Bankruptcy Protection
(RTTNews) - Lipella Pharmaceuticals Inc. announced that it has filed a voluntary petition for relief under Chapter 11 of the U.S. Bankruptcy Code in the United States Bankruptcy Court for the Western District of Pennsylvania. The company intends to pursue a 363 sale process under Chapter 11 in order to maximize value for its creditors.
In connection with the Chapter 11 proceedings, the company expects to seek customary "first-day" relief. If approved by the Court, this relief would allow Lipella to continue day-to-day operations, including maintaining cash management systems and paying employee wages and benefits in the ordinary course.
LIPO closed Monday's regular trading at $0.0700, down $0.0020 or 2.78%.
Founded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new generation of investors, RTTNews has expanded steadily over the years to become a trusted provider of content for a wide array of subjects across several platforms. RTT's Financial Newswire is relied upon by some of the world's largest financial institutions, including banks, brokerages, trading platforms and financial exchanges.